about
Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis.Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin.Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin SupplementationRole of extracellular vesicles in the development of sepsis-induced coagulopathyOh, how hard it is to open the gate for sepsis trials: lessons from SCARLETThe wind changed direction and the big river still flows: from EUPHRATES to TIGRISSepsis-associated disseminated intravascular coagulation and its differential diagnosesNewly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High MortalityDerangement of the endothelial glycocalyx in sepsisEfficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysisDifferential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTHProtection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsisThe progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseasesDiagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathyUsefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular CoagulationProposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulationDiagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulationDIC in obstetrics: Diagnostic score, highlights in management, and international registry-communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and HaemostasisRE: The prothrombin time ratio is not a more effective marker for evaluating sepsis-induced coagulopathy than fibrin-related markers: Response to the Letter-to-the-Editor by Dr WadaThe unique characteristics of COVID-19 coagulopathyCoagulopathy in COVID-19
P50
Q47343207-A182283C-E300-47CB-8BCB-F031E97FA445Q52563187-A6F442E9-0021-4447-97E5-170329DA6111Q57159238-F8458480-EA4B-4607-BF7B-5CCECB4484EEQ58121058-2E6DC162-D879-4CD7-8F58-C2D39D4F527CQ60949827-B1354A5D-1E76-479A-8ED2-26C8B27390A4Q64053636-28200701-5E4B-4730-B6DC-D3FF88D8FEBBQ64270699-64DB2A48-7A8A-46BC-916A-B525FE828681Q88546304-BE698304-C3F7-4BC8-AE7B-3263096A2816Q90738369-53D6794B-4AD1-4192-9984-566ACCA0EAC6Q90825388-7C5C7B9D-05F2-448C-8838-0F1D194F4A88Q90933256-964DCB45-2901-4DCB-9962-9999029CBD3FQ91451340-93B7EC36-D9F8-4734-A467-02130D906B0BQ91793826-2D083277-055F-498D-A164-F89613EFCBC7Q91867008-1472F279-0A69-44D0-8EBE-4BB4577C4EA4Q91938906-1516C3A5-8B6C-4CBF-B375-3BCA7EDE5C68Q92104310-E33C5951-EA73-403C-A2EF-AE78CB3CBF73Q92609913-7AEF7408-199F-4A50-88FC-401D3F9E31A5Q92893606-370B4529-039B-468A-8774-8D977A80B9C3Q96115536-2E1568FE-D50A-4334-A373-F4696CB3E991Q96584241-3612CD04-4B9E-40D2-ACA2-0EC1DE3881D3Q96586141-052FEC47-8020-4D7F-A6BE-E3914015D3F1
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-0255-4088
@en
name
Toshiaki Iba
@ast
Toshiaki Iba
@en
Toshiaki Iba
@es
Toshiaki Iba
@nl
type
label
Toshiaki Iba
@ast
Toshiaki Iba
@en
Toshiaki Iba
@es
Toshiaki Iba
@nl
prefLabel
Toshiaki Iba
@ast
Toshiaki Iba
@en
Toshiaki Iba
@es
Toshiaki Iba
@nl
P106
P31
P496
0000-0002-0255-4088